FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma

IFPMA institutes new pharma marketing rules

Tools
Tags
pharmaceutical companies
pharma

International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has revealed a new code that limits gifts from pharmaceutical reps to physicians. The new code, whose applicability extends to every country and is required of all IFPMA members, imposes even stricter and clearer requirements on pharmaceutical companies, to ensure the ethical promotion of their products to healthcare professionals. The provisions state:

  • Pharma reps can't give doctors money or expensive gifts in order to influence their prescription drug selection
  • Medical and scientific meetings held by members can't take place at "renowned or extravagant venues"
  • Hospitality and entertainment can't exceed what physicians would provide for themselves if they were paying

The IFPMA concludes that if a company has been found to have broken the ethical rules in the new code, it will publicly announce the company's name and obtain the company's written agreement to end the objectionable practice concerned.

To get all the details:
- check out the IFPMA's press release

Related Articles:
Henry Ford bans pharma perks, vendor drop-ins. Report
Doctors weigh in on the pros and cons of accepting drug/device freebies. Letters

Bookmark and Share
Get Your FREE FierceHealthcare Email Newsletter:
Be the first to comment

Comments

The "dumbing down" of the American physician has taken another step forward as they are forced to goose-step their way toward uniformity of practice, thought, and expertise. The PC police are out in full force to protect the people from evil and stupid doctors who only prescribe medications if they were bribed or they found it on formulary.

Anne,
last year one of my duties was as Compliance Officer for a large physician entity. I waged a valiant battle to ban the big pharma reps from continuing their aggregious marketing practices, many of which flew in the face of the IFPMA's guidelines. I was unsuccessful in getting them to divulge their reports which track prescription activity and volume, BY DOCTOR. It is well known that they use this data to target individual doc's with marketing and stepped-up pressure, often to the doc's ancillary and support staff (e.g., lunches, gift certificates and other tactics). The pharma's claimed they didn't own the data warehouse for prescription activity; that they contract out to 3rd party companies to manage this. I called the national compliance/legal dept's. of several pharma's and was given a complete runaround. Have other providers found this the case? Why can't providers have access to their own prescription volume reports? A shocking fact is that many "experienced" drug reps make considerably more than the doctors themselves -- certainly more than PCP's. Have any skeptic spend a day in a large MD office and watch the game in action!

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.